Back

Challenges of managing hyperkalemia in HF patients while maintaining RAASi therapy

12 May 2024 (12:30 - 12:45)
Organised by: Logo
Congress Presentation Part of: Early intervention and long-term success: navigating hyperkalemia in cardiorenal disease Pharmacotherapy Open Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)

2 More presentations in this session

Presentation thumbnail
Interactive panel & case discussion: practical considerations implementing evidence and guidelines on novel potassium binders for achieving long term goals
Professor J. Burton (Leicester, GB) Doctor C. Bonanad Lozano (Valencia, ES) Doctor A. Wong (Bridgend, GB)
Slides
Presentation thumbnail
Summarising multidisciplinary strategies: Where do we go from here?
Professor G. Savarese (Stockholm, SE)
Slides

Access the full session

Session thumbnail
Early intervention and long-term success: navigating hyperkalemia in cardiorenal disease
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 12:30 CET
You may be interested in
thumbnail
Congress Session
Breaking barriers in guideline-based RAASi-therapy: solving issues with hyperkalemia
20 May 2023
thumbnail
Congress Presentation
Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients
29 June 2021
thumbnail
Congress Session
Clinical approach to the complex heart failure patient
18 May 2025
thumbnail
Congress Session
Hyperkalaemia management 101: supporting renin-angiotensin-aldosterone system inhibitor optimisation
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources